Price data is not available
Kairos Pharma Ltd
KAPAAMEX
The average analyst price target for Kairos Pharma is $59.50. Of 4 analysts, 4 rate it Buy. Targets range from $28 to $84. The latest change came on Apr 3, 2025, when HC Wainwright & Co. initiated coverage of Kairos Pharma with a Buy rating and a $84 price target.
Price Target Range — 5 Quarters
Analyst Consensus — 4 Analysts
Rating Trend — Last 9 Months
